Biologic quantification, made simple & reliable.
Precision made practical
Supporting faster, more confident decisions with accessible tools.
We develop tools that simplify the measurement of biologics without compromising on data quality or performance. Whether you’re working in research, development, or process optimisation, our platform is designed to deliver reliable results, streamline everyday workflows, and fit seamlessly into your existing lab environment.
Amperia™: Fast, accurate, accessible quantification
Amperia™ is powered by RED (Redox Electrochemical Detection) for direct measurement of biologics.
Built on patented sensor technology and designed for usability, it delivers consistent results through streamlined workflows. Amperia™ supports a wide range of biomolecules, including proteins, viral vectors, tagged constructs, and more, across applications from early research to process development.
Our products.
We develop products that simplify and accelerate the quantification of proteins, viral vectors, and other biomolecules.
Our system includes user-friendly instrumentation, assay kits tailored for different targets, precision sensors, and validated reagents, designed to work together and support reliable, efficient analysis across a wide range of applications.
Platform
Compact systems for efficient quantification workflows.
Assay Kits
Ready-to-use kits for specific applications.
Sensors
Detection components tailored to your assay.
Consumables & Reagents
Validated components for smooth daily use.
Tools for biologics innovation.
We build tools that help teams move faster, with confidence – removing barriers between measurement and decision-making.
Whether you’re developing new cell lines, comparing antibody formats, or advancing gene therapies, our platform supports the practical, day-to-day work of biologics development. It’s designed to fit into real workflows, deliver consistent results, and make complex measurement easier to manage.
Resource library.
Case studies.
Application notes.
What's new.
Abselion’s CEO, Dr. Ruizhi Wang, was recently featured in a BioCompare editorial article, “Cell-Based Gene Therapies: Challenges and Advances in...
Abselion is featured in Biocompare’s latest editorial on antibody libraries — indispensable tools for research and drug discovery. In this Q&A,...
NHS Blood and Transplant Clinical Biotechnology Centre implements the Amperia™ system to streamline viral vector process development for novel gene...
We’re excited to share that Abselion is featured in the Spring 2025 issue of Innovations in Pharmaceutical Technology (IPT), highlighting the role...
Find out how Abselion can help accelerate your workflows.